Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration
- PMID: 16870527
- DOI: 10.1016/S1473-3099(06)70549-7
Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration
Abstract
Tuberculosis is the oldest of the world's current pandemics and causes 8.9 million new cases and 1.7 million deaths annually. The disease is among the most common causes of morbidity and mortality in people living with HIV. However, tuberculosis is more than just part of the global HIV problem; well-resourced tuberculosis programmes are an important part of the solution to scaling-up towards universal access to comprehensive HIV prevention, diagnosis, care, and support. This article reviews the impact of the interactions between tuberculosis and HIV in resource-limited settings; outlines the recommended programmatic and clinical responses to the dual epidemics, highlighting the role of tuberculosis/HIV collaboration in increasing access to prevention, diagnostic, and treatment services; and reviews progress in the global response to the epidemic of HIV-related tuberculosis.
Similar articles
-
Synergistic pandemics: confronting the global HIV and tuberculosis epidemics.Clin Infect Dis. 2010 May 15;50 Suppl 3:S67-70. doi: 10.1086/651475. Clin Infect Dis. 2010. PMID: 20397958 No abstract available.
-
From HIV to tuberculosis and back again: a tale of activism in 2 pandemics.Clin Infect Dis. 2010 May 15;50 Suppl 3:S260-6. doi: 10.1086/651500. Clin Infect Dis. 2010. PMID: 20397957 Review.
-
Prevention of tuberculosis in people living with HIV.Clin Infect Dis. 2010 May 15;50 Suppl 3:S215-22. doi: 10.1086/651494. Clin Infect Dis. 2010. PMID: 20397951 Review.
-
Tuberculosis in HIV-infected patients: a comprehensive review.Clin Microbiol Infect. 2004 May;10(5):388-98. doi: 10.1111/j.1469-0691.2004.00758.x. Clin Microbiol Infect. 2004. PMID: 15113314 Review.
-
Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study.Lancet HIV. 2016 Mar;3(3):e120-31. doi: 10.1016/S2352-3018(15)00252-0. Epub 2016 Feb 2. Lancet HIV. 2016. PMID: 26939735
Cited by
-
"Universal test and treat" program reduced TB incidence by 75% among a cohort of adults taking antiretroviral therapy (ART) in Gurage zone, South Ethiopia.Trop Dis Travel Med Vaccines. 2020 Jul 31;6:12. doi: 10.1186/s40794-020-00113-3. eCollection 2020. Trop Dis Travel Med Vaccines. 2020. PMID: 32864154 Free PMC article.
-
Scaling up integration: development and results of a participatory assessment of HIV/TB services, South Africa.Health Res Policy Syst. 2010 Jul 13;8:23. doi: 10.1186/1478-4505-8-23. Health Res Policy Syst. 2010. PMID: 20626884 Free PMC article.
-
Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: experiences from 3-year follow-up.Eur J Clin Microbiol Infect Dis. 2018 Jul;37(7):1259-1263. doi: 10.1007/s10096-018-3242-6. Epub 2018 Apr 20. Eur J Clin Microbiol Infect Dis. 2018. PMID: 29679254
-
Pregnancy outcomes in HIV-infected women receiving long-term isoniazid prophylaxis for tuberculosis and antiretroviral therapy.Infect Dis Obstet Gynecol. 2013;2013:195637. doi: 10.1155/2013/195637. Epub 2013 Mar 7. Infect Dis Obstet Gynecol. 2013. PMID: 23533318 Free PMC article. Clinical Trial.
-
Incidence and predictors of tuberculosis among adult people living with human immunodeficiency virus at the University of Gondar Referral Hospital, Northwest Ethiopia.BMC Infect Dis. 2013 Jun 28;13:292. doi: 10.1186/1471-2334-13-292. BMC Infect Dis. 2013. PMID: 23806088 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical